We use cookies on our website. Carry on browsing if you’re happy with this or find out more

Events

:

The Promise of Interleukin-2 Therapy 2019

Dates

13 Nov 2019 - 16 Nov 2019

Location

Paris, France

Venue

Centre international de Conférence Sorbonne Université

We will present 'KY1043, a novel PD-L1 IL-2 immunocytokine directed towards IL-2Rα (CD25), delivers potent anti-tumour activity in vivo' at The Promise of Interleukin-2 Therapy 2019 event in Paris.

The first meeting fully dedicated to biology and therapeutic use of IL-2.

The latest news and press from the Kymab network

View Kymab news